|
|
Q4 2018
Filed on Feb 01, 2019
|
26,426
|
N/A
|
|
|
|
Q4 2018
Filed on Feb 01, 2019
|
1,811
|
N/A
|
|
|
|
Q4 2018
Filed on Feb 01, 2019
|
12,683
|
N/A
|
|
|
|
Q4 2018
Filed on Feb 01, 2019
|
4,200
|
N/A
|
|
|
|
Q4 2018
Filed on Feb 01, 2019
|
2,866
|
N/A
|
|
|
|
Q4 2018
Filed on Feb 01, 2019
|
28,179
|
N/A
|
|
|
|
|
|
Q4 2018
Filed on Feb 01, 2019
|
20,900
|
N/A
|
|
|
|
Q4 2018
Filed on Feb 01, 2019
|
13,806
|
N/A
|
|
|
|
Q4 2018
Filed on Feb 01, 2019
|
10,669
|
N/A
|
|
|
|
Q4 2018
Filed on Feb 01, 2019
|
7,804
|
$20.07 - $46.7
$157K - $364K
|
|
|
|
Q4 2018
Filed on Feb 01, 2019
|
100,022
|
N/A
|
|
|
|
Q4 2018
Filed on Feb 01, 2019
|
42,165
|
$13.35 - $20.11
$563K - $848K
|
|
|
|
Q4 2018
Filed on Feb 01, 2019
|
23,000
|
N/A
|
|
|
|
Q4 2018
Filed on Feb 01, 2019
|
203,245
|
$0.53 - $1.11
$108K - $226K
|
|
|
|
Q4 2018
Filed on Feb 01, 2019
|
9,375
|
N/A
|
|
Bellerophon Therapeutics Inc
|
Q4 2018
Filed on Feb 01, 2019
|
45,517
|
N/A
|
|
Northstar Realty Europe Corp
|
Q4 2018
Filed on Feb 01, 2019
|
13,806
|
N/A
|
|
|
|
Q4 2018
Filed on Feb 01, 2019
|
20,652
|
N/A
|
|
|
|
|
|
Q4 2018
Filed on Feb 01, 2019
|
8,175
|
N/A
|
|
|
|
Q4 2018
Filed on Feb 01, 2019
|
3,653
|
N/A
|
|
|
|
Q4 2018
Filed on Feb 01, 2019
|
10,648
|
N/A
|
|
|
|
Q4 2018
Filed on Feb 01, 2019
|
11,837
|
N/A
|
|
|
|
Q4 2018
Filed on Feb 01, 2019
|
23,158
|
N/A
|
|
|
|
Q4 2018
Filed on Feb 01, 2019
|
6,061
|
N/A
|
|
|
|
Q4 2018
Filed on Feb 01, 2019
|
10,700
|
N/A
|
|
|
|
Q4 2018
Filed on Feb 01, 2019
|
20,000
|
N/A
|
|
|
|
Q4 2018
Filed on Feb 01, 2019
|
3,400
|
$70.31 - $73.59
$239K - $250K
|
|
|
|
Q4 2018
Filed on Feb 01, 2019
|
10,171
|
$12.02 - $12.44
$122K - $127K
|
|
|
|
Q4 2018
Filed on Feb 01, 2019
|
11,037
|
$5.37 - $8.39
$59.3K - $92.6K
|
|
|
|
Q4 2018
Filed on Feb 01, 2019
|
48,847
|
N/A
|
|
Franklin Finl Network Inc
|
Q4 2018
Filed on Feb 01, 2019
|
5,755
|
N/A
|
|
|
|
Q4 2018
Filed on Feb 01, 2019
|
9,535
|
N/A
|
|
|
|
Q4 2018
Filed on Feb 01, 2019
|
20,049
|
N/A
|
|
Sequential Brnds Group Inc N
|
Q4 2018
Filed on Feb 01, 2019
|
42,596
|
N/A
|
|
|
|
Q4 2018
Filed on Feb 01, 2019
|
10,030
|
N/A
|
|
|
|
|
|
Q4 2018
Filed on Feb 01, 2019
|
6,906
|
$31.26 - $32.06
$216K - $221K
|
|
|
|
Q4 2018
Filed on Feb 01, 2019
|
18,528
|
N/A
|
|
|
|
Q4 2018
Filed on Feb 01, 2019
|
16,582
|
N/A
|
|
|
|
Q4 2018
Filed on Feb 01, 2019
|
59,638
|
N/A
|
|
|
|
Q4 2018
Filed on Feb 01, 2019
|
30,000
|
$1.39 - $2.82
$41.7K - $84.6K
|
|
Insys Therapeutics Inc New
|
Q4 2018
Filed on Feb 01, 2019
|
15,205
|
N/A
|
|
Goldman Sachs Mlp Inc Opp Fd
|
Q4 2018
Filed on Feb 01, 2019
|
10,850
|
N/A
|
|
Franklin LTD Duration Incm T
|
Q4 2018
Filed on Feb 01, 2019
|
12,322
|
N/A
|
|
|
|
Q4 2018
Filed on Feb 01, 2019
|
2,748
|
N/A
|
|
|
|
Q4 2018
Filed on Feb 01, 2019
|
10,134
|
N/A
|
|
|
|
Q4 2018
Filed on Feb 01, 2019
|
3,356
|
N/A
|
|
|
|
Q4 2018
Filed on Feb 01, 2019
|
68,374
|
N/A
|
|
|
|
Q4 2018
Filed on Feb 01, 2019
|
9,113
|
N/A
|
|
|
|
Q4 2018
Filed on Feb 01, 2019
|
33,355
|
N/A
|
|
|
|
Q4 2018
Filed on Feb 01, 2019
|
12,322
|
$8.73 - $10.24
$108K - $126K
|
|